Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.
about
Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferretsPhase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteersH5N1 vaccines in humansA Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and FerretsImpact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model.A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine.Flexible label-free quantitative assay for antibodies to influenza virus hemagglutininsAntibody dynamics of 2009 influenza A (H1N1) virus in infected patients and vaccinated people in China.Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs.B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccinationInfluence of prior influenza vaccination on antibody and B-cell responses.Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens.Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice.Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization.A controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responsesDistinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccinesImplications of broadly neutralizing antibodies in the development of a universal influenza vaccine.Lack of PD-L1 expression by iNKT cells improves the course of influenza A infection.Long term persistence of IgE anti-influenza virus antibodies in pediatric and adult serum post vaccination with influenza virus vaccine.Collectivism/individualism and its relationship to behavioral and physiological immunity.Time to peak serum antibody response to influenza vaccine in the elderlyLongevity of B-cell and T-cell responses after live attenuated influenza vaccination in children.Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus.A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individualsMucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virusImpact of Estrogen Therapy on Lymphocyte Homeostasis and the Response to Seasonal Influenza Vaccine in Post-Menopausal Women.The human side of influenza.Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.Activation of virus replication after vaccination of HIV-1-infected individuals.Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccineInduction and maintenance of anti-influenza antigen-specific nasal secretory IgA levels and serum IgG levels after influenza infection in adults.High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults.Blocking interhost transmission of influenza virus by vaccination in the guinea pig model.Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum.Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccinesLive Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils.Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines
P2860
Q21563426-74EC1900-FC64-447B-8ECC-AFBF14027877Q24545856-414B6292-F071-42CB-898D-183E8D6D3F84Q27000896-B86087F4-74A0-4B59-A579-C1E9D3FBC4C6Q30204020-AD87B451-39F2-497A-9A84-82DB6CB132A0Q30354091-F8D3E376-D95E-4895-A0CD-FE2FF2C05712Q30360436-D9489C25-894E-415B-8551-2EBDF533B79BQ30377443-9DD46AF5-105C-43F7-9DA7-B8BAAED97FF2Q30377447-11B8DDD5-1AFC-4032-ACE7-FFE2DDA04679Q30384943-68AC9451-6D38-445F-B952-78C832004680Q30391853-59C9D0BF-FA15-4150-9C2F-E7A78C0724DDQ30400114-EEB1E5EA-B617-4C79-B547-CF65521EC4A3Q30419702-0C8187DF-4D56-49B1-B816-B14BA577D5DAQ30429248-0A543B64-1C12-49C3-A076-0809B361A013Q33361605-1293EDB9-41F3-4339-BB31-379C4A690585Q33592225-415EB679-AECD-4468-A9AC-09FAB9D8108CQ33852342-CE646103-B38D-4854-82A5-D9AEB04A7A35Q33853571-3130CE52-7599-4FB2-BFA2-3ED3C631AEFFQ34000204-CB4185B7-D964-4910-B2B1-2EB6E6916622Q34354440-05FBA7C0-D9C2-4295-8CAA-7B70247FA89DQ34520430-D81C70BC-A024-4002-B9DD-C044DFCA14A5Q34649276-F06DF09A-1132-4448-8454-12FEA37C8CDAQ34730017-979C1E43-3C80-4610-90D7-99AA0299CFC4Q35136165-A64381E6-BA1C-4BC4-ACF1-9FD50BDDA23DQ35226936-E3742C7C-A9A7-479D-80F0-984A24A1B649Q35531941-2CFAD777-70E2-45C1-ACBF-0DD0FFA26078Q35618515-3E6FDE1A-AA1E-4CED-816D-6949F40B4319Q35815281-111AC3E7-65A7-485E-BB7F-5EB3AC62F188Q35849627-AC6DF088-80A0-4E7E-8C65-29A670BB654AQ35918253-E5D4C815-1297-4E87-AE61-6A520048CED7Q36055988-A59B493E-ED9E-4B38-B447-027467616F74Q36087562-5ADB33F6-E1D7-42F4-A26C-6003842A1530Q36365672-AF2F8E78-7B03-4E34-8ADD-2738259A878AQ36889707-C74CC939-40A3-4EF8-9DE6-DA2580301010Q37087174-5B55DBB6-9987-4814-9D5C-EC9EE53E53B0Q37093884-5ADCF0CE-E641-4F28-BE29-B6ABD0D183E4Q37127910-B6B7BC2F-F20A-4D7C-AC52-76BAFAC8EBA6Q37138345-7ABEDD5D-5047-4D7D-9302-C0F725EE961AQ37149005-3E0C0F52-9531-4C8A-A4C0-1F9DE1373FCBQ37161924-F3DE90FB-4924-4B9B-83C1-92678D7E4E1DQ37163516-93743DE0-F5BD-477D-978D-E0D9EE76750D
P2860
Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1986
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development and persistence of ...... ted influenza A virus vaccine.
@en
Development and persistence of ...... ted influenza A virus vaccine.
@nl
type
label
Development and persistence of ...... ted influenza A virus vaccine.
@en
Development and persistence of ...... ted influenza A virus vaccine.
@nl
prefLabel
Development and persistence of ...... ted influenza A virus vaccine.
@en
Development and persistence of ...... ted influenza A virus vaccine.
@nl
P2860
P921
P1476
Development and persistence of ...... ated influenza A virus vaccine
@en
P2093
B R Murphy
M L Clements
P2860
P407
P577
1986-01-01T00:00:00Z